Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**l-methylfolate + pyridoxal 5'-phosphate + methylcobalamin** is a combination of three biologically active B vitamins: L-methylfolate (active folate, vitamin B9), pyridoxal 5'-phosphate (active vitamin B6), and methylcobalamin (active vitamin B12). This combination is primarily indicated for the dietary management of endothelial dysfunction associated with diabetic peripheral neuropathy, where these vitamins help restore proper nerve function, improve peripheral blood flow, and reduce homocysteine levels. They are also used to address general B vitamin deficiencies, elevated homocysteine (a cardiovascular risk factor), memory loss, and certain cognitive disorders. The mechanism involves providing active coenzyme forms of essential vitamins needed for homocysteine metabolism, red blood cell production, and neuronal support.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on l-methylfolate + pyridoxal 5'-phosphate + methylcobalamin.